HC Wainwright Reiterates "Buy" Rating for Transcat (NASDAQ:TRNS)

Transcat (NASDAQ:TRNS - Get Free Report)'s stock had its "buy" rating reiterated by investment analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a $116.00 target price on the scientific and technical instruments company's stock, up from their prior target price of $106.00. HC Wainwright's target price would suggest a potential upside of 27.03% from the stock's previous close. HC Wainwright also issued estimates for Transcat's Q1 2026 earnings at $0.41 EPS, Q2 2026 earnings at $0.26 EPS, Q3 2026 earnings at $0.10 EPS, Q4 2026 earnings at $0.70 EPS and FY2026 earnings at $1.48 EPS.

TRNS has been the subject of a number of other reports. Oppenheimer lowered Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. Northland Securities reiterated a "market perform" rating and set a $85.00 target price (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Finally, Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a report on Tuesday, May 20th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $114.00.

Transcat Price Performance

TRNS traded down $0.31 during trading on Wednesday, reaching $91.32. 70,643 shares of the company traded hands, compared to its average volume of 82,161. The company has a market cap of $850.10 million, a P/E ratio of 49.36 and a beta of 0.69. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. Transcat has a 12-month low of $67.56 and a 12-month high of $147.12. The firm has a fifty day simple moving average of $79.46 and a 200 day simple moving average of $89.50.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). The company had revenue of $77.13 million for the quarter, compared to the consensus estimate of $76.40 million. Transcat had a return on equity of 7.23% and a net margin of 6.22%. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities analysts forecast that Transcat will post 2.3 EPS for the current year.

Institutional Investors Weigh In On Transcat

Large investors have recently added to or reduced their stakes in the stock. Centiva Capital LP lifted its stake in shares of Transcat by 6.0% in the 4th quarter. Centiva Capital LP now owns 3,009 shares of the scientific and technical instruments company's stock valued at $318,000 after purchasing an additional 171 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Transcat by 0.6% during the 1st quarter. Bank of New York Mellon Corp now owns 27,916 shares of the scientific and technical instruments company's stock valued at $2,078,000 after buying an additional 172 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Transcat by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,137 shares of the scientific and technical instruments company's stock worth $543,000 after buying an additional 194 shares during the last quarter. Diamond Hill Capital Management Inc. boosted its stake in Transcat by 3.4% during the first quarter. Diamond Hill Capital Management Inc. now owns 6,353 shares of the scientific and technical instruments company's stock worth $473,000 after buying an additional 210 shares during the period. Finally, US Bancorp DE increased its position in Transcat by 14.6% during the first quarter. US Bancorp DE now owns 1,770 shares of the scientific and technical instruments company's stock valued at $132,000 after acquiring an additional 226 shares during the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.